...糖尿病研究进展 - 神经症 内胃肠激素，如抑胃肽(gastric inhellobitory polypeptide,GIP)、胰高血糖样肽(glucagon-like peptide 1,GLP-1)、Ghrelin、肽YY(peptide YY，PYY)、瘦素(leptin)、脂连素(adipon..
基于1个网页-相关网页
胰高血糖素样肽-1 Glucagon-like peptide ; GLP
胰高血糖素样肽 glucagon-like peptide ; GLP ; Anti-GLP ; GLP-1R peptide
人胰高血糖素样肽 Human Glucagon-like peptide ; Human GLP ; GLP 1 Human
人胰高血糖素样肽-1 Human Glucagon-like peptide ; Human GLP ; GLP 1 Human
胰高血糖素样肽1 Glucagon-like peptide
胰高血糖素样肽-2 Glucagon-like peptide
人胰高血糖素样肽1 Human GLP
大鼠胰高血糖素样肽1 Rat Glp ; Glp-1 ELISA Kit
胰高血糖素样多肽 Glucagon-like peptide
研究结论：这些数据显示胃旁路手术早期胰高血糖素样肽- 1和胰高血糖素的大量释放以及肠促胰岛素效应的增加和体重减轻没有关系而是和手术操作有关。
Conclusions: These data suggest that early after GBP, the greater GLP-1 and GIP release and improvement of incretin effect are related not to weight loss but rather to the surgical procedure.
胰高血糖素样肽- 1对胃排空、食欲和食物摄取的作用是否涉及人体中糊精的释放？
Do the Actions of Glucagon-Like Peptide-1 on Gastric Emptying, Appetite, and Food Intake Involve Release of Amylin in Humans?
目的本研究的目的是探讨人工甜味剂对人类葡萄糖、胰岛素和胰高血糖素样肽(GLP) - 1的影响。
OBJECTIVE the goal of this study was to determine the effect of artificial sweeteners on glucose, insulin, and glucagon-like peptide (GLP) -1 in humans.
应用推荐